United States Biotechnology & Medical Research

MyoKardia Inc (MYOK)

Track

Ticker: MYOK Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Planned sale 2 Jul 2020
Value US$3,710,093.07 | Price 462.52 | Shares 21,065 (+26.6%)
Planned sale 2 Jul 2020
Value US$4,631,787.93 | Price 17.54 | Shares 91,152 (-12.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-07-07 2020-07-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
21,065 +26.6%
462.52
US$3,710,093 		21,065 +26.6% 462.52 US$3,710,093
2020-07-07 2020-07-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
91,152 -12.2%
17.54
US$4,631,788 		91,152 -12.2% 17.54 US$4,631,788
2020-07-01 2020-06-30 S Sale
1.5
CRANSTON MARY B
Non-Executive Director
35,375 -41.1%
456.51
US$1,441,281 		35,375 -41.1% 456.51 US$1,441,281
2020-07-01 2020-06-30 S Sale
1.5
CRANSTON MARY B
Non-Executive Director
300 -1.4%
97.25
US$29,176 		300 -1.4% 97.25 US$29,176
2020-07-01 2020-06-29 S Sale
1.5
CRANSTON MARY B
Non-Executive Director
371 -100.0%
98.68
US$36,611 		371 -100.0% 98.68 US$36,611
2020-06-04 2020-06-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
319 -1.3%
104.64
US$33,382 		319 -1.3% 104.64 US$33,382
2020-06-04 2020-06-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,885 -7.2%
103.77
US$195,609 		1,885 -7.2% 103.77 US$195,609
2020-06-04 2020-06-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,396 -5.0%
102.78
US$143,481 		1,396 -5.0% 102.78 US$143,481
2020-06-04 2020-06-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
800 -2.8%
101.72
US$81,378 		800 -2.8% 101.72 US$81,378
2020-06-04 2020-06-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
600 -2.1%
100.60
US$60,357 		600 -2.1% 100.60 US$60,357
2020-05-20 2020-05-18 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
10,000 -25.6%
125.00
US$1,250,000 		10,000 -25.6% 125.00 US$1,250,000
2020-05-13 2020-05-11 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
600 -1.5%
103.33
US$61,998 		600 -1.5% 103.33 US$61,998
2020-05-13 2020-05-11 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
3,519 -8.1%
102.56
US$360,921 		3,519 -8.1% 102.56 US$360,921
2020-05-13 2020-05-11 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
18,581 -30.1%
101.90
US$1,893,486 		18,581 -30.1% 101.90 US$1,893,486
2020-05-13 2020-05-11 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,700 -2.7%
100.51
US$170,860 		1,700 -2.7% 100.51 US$170,860
2020-05-13 2020-05-11 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
600 -0.9%
98.69
US$59,213 		600 -0.9% 98.69 US$59,213
2020-05-06 2020-05-04 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
305 -0.4%
60.15
US$18,346 		305 -0.4% 60.15 US$18,346
2020-05-06 2020-05-04 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,909 -3.8%
59.10
US$171,916 		2,909 -3.8% 59.10 US$171,916
2020-05-06 2020-05-04 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
400 -0.5%
58.05
US$23,218 		400 -0.5% 58.05 US$23,218
2020-05-06 2020-05-04 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,386 -1.8%
56.93
US$78,907 		1,386 -1.8% 56.93 US$78,907
2020-04-20 2020-04-16 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.3%
55.00
US$55,000 		1,000 -1.3% 55.00 US$55,000
2020-04-10 2020-04-08 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,500 -1.9%
50.00
US$75,000 		1,500 -1.9% 50.00 US$75,000
2020-04-07 2020-04-06 S Sale
0.5
Harris Taylor C.

Chief Financial Officer

Officer
1,305 -14.9%
46.99
US$61,322 		1,305 -14.9% 46.99 US$61,322
2020-04-06 2020-04-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
600 -0.8%
46.23
US$27,736 		600 -0.8% 46.23 US$27,736
2020-04-06 2020-04-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
300 -0.4%
45.35
US$13,605 		300 -0.4% 45.35 US$13,605
2020-04-06 2020-04-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.2%
44.47
US$44,469 		1,000 -1.2% 44.47 US$44,469
2020-04-06 2020-04-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
600 -0.7%
43.51
US$26,107 		600 -0.7% 43.51 US$26,107
2020-03-04 2020-03-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
22 -0.0%
65.97
US$1,451 		22 -0.0% 65.97 US$1,451
2020-03-04 2020-03-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,800 -2.2%
65.19
US$117,346 		1,800 -2.2% 65.19 US$117,346
2020-03-04 2020-03-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,070 -2.4%
64.35
US$133,203 		2,070 -2.4% 64.35 US$133,203
2020-03-04 2020-03-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,108 -1.3%
63.40
US$70,246 		1,108 -1.3% 63.40 US$70,246
2020-02-05 2020-02-03 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.1%
69.74
US$69,744 		1,000 -1.1% 69.74 US$69,744
2020-02-05 2020-02-03 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
4,000 -4.4%
69.27
US$277,077 		4,000 -4.4% 69.27 US$277,077
2020-02-03 2020-02-01 S Sale
0.6
Fairey William

See Remarks
2,899 -35.7%
68.04
US$197,248 		2,899 -35.7% 68.04 US$197,248
2020-01-14 2020-01-14 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
5,000 -5.2%
75.39
US$376,964 		5,000 -5.2% 75.39 US$376,964
2020-01-07 2020-01-06 S Sale
0.5
Harris Taylor C.

Chief Financial Officer
1,683 -25.2%
68.45
US$115,203 		1,683 -25.2% 68.45 US$115,203
2020-01-07 2020-01-06 S Sale
LADD CYNTHIA J

General Counsel
1,849 -39.3%
68.45
US$126,566 		1,849 -39.3% 68.45 US$126,566
2020-01-07 2020-01-06 S Sale
McDowell Robert Scott

Chief Scientific Officer
2,650 -33.0%
68.45
US$181,395 		2,650 -33.0% 68.45 US$181,395
2020-01-07 2020-01-06 S Sale
Bauer Jake

Chief Business Officer
2,466 -4.1%
68.45
US$168,800 		2,466 -4.1% 68.45 US$168,800
2020-01-07 2020-01-06 S Sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
12,687 -11.6%
68.45
US$868,439 		12,687 -11.6% 68.45 US$868,439
2020-01-03 2020-01-03 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,084 -1.9%
72.27
US$150,617 		2,084 -1.9% 72.27 US$150,617
2020-01-03 2020-01-03 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,616 -2.3%
71.59
US$187,287 		2,616 -2.3% 71.59 US$187,287
2020-01-03 2020-01-03 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
300 -0.3%
70.35
US$21,105 		300 -0.3% 70.35 US$21,105
2019-12-23 2019-12-20 PlS Planned sale Bauer Jake

Chief Business Officer

Officer
18,916 -30.3%
70.07
US$1,325,421 		18,916 -30.3% 70.07 US$1,325,421
2019-12-04 2019-12-02 PlS Planned sale GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
4,350 -4.8%
65.14
US$283,342 		4,350 -4.8% 65.14 US$283,342
2019-12-04 2019-12-02 PlS Planned sale GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
650 -0.7%
64.24
US$41,755 		650 -0.7% 64.24 US$41,755
2019-12-02 2019-11-29 PlS Planned sale Bauer Jake

Chief Business Officer

Officer
800 -1.7%
66.32
US$53,056 		800 -1.7% 66.32 US$53,056
2019-12-02 2019-11-29 PlS Planned sale Bauer Jake

Chief Business Officer

Officer
7,336 -13.8%
65.52
US$480,655 		7,336 -13.8% 65.52 US$480,655
2019-12-02 2019-11-27 PlS Planned sale Bauer Jake

Chief Business Officer

Officer
13,096 -19.8%
65.13
US$852,977 		13,096 -19.8% 65.13 US$852,977
2019-11-06 2019-11-04 PlS Planned sale GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
5,000 -5.2%
59.07
US$295,364 		5,000 -5.2% 59.07 US$295,364
2019-10-04 2019-10-03 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.0%
55.00
US$55,000 		1,000 -1.0% 55.00 US$55,000
2019-10-04 2019-10-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
758 -0.8%
53.10
US$40,248 		758 -0.8% 53.10 US$40,248
2019-10-04 2019-10-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,542 -2.5%
52.29
US$132,933 		2,542 -2.5% 52.29 US$132,933
2019-10-04 2019-10-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
700 -0.7%
51.33
US$35,930 		700 -0.7% 51.33 US$35,930
2019-09-24 2019-09-23 PlS Planned sale
Lee June

EVP, Chief Development Officer
4,161 -50.0%
61.09
US$254,191 		4,161 -50.0% 61.09 US$254,191
2019-09-24 2019-09-23 PlS Planned sale
Lee June

EVP, Chief Development Officer
800 -8.8%
59.95
US$47,960 		800 -8.8% 59.95 US$47,960
2019-09-24 2019-09-23 PlS Planned sale
Lee June

EVP, Chief Development Officer
4,161 -31.3%
58.97
US$245,389 		4,161 -31.3% 58.97 US$245,389
2019-09-24 2019-09-23 PlS Planned sale
Lee June

EVP, Chief Development Officer
3,929 -22.8%
58.33
US$229,184 		3,929 -22.8% 58.33 US$229,184
2019-09-24 2019-09-20 PlS Planned sale
Bauer Jake

Chief Business Officer
19,700 -23.0%
60.09
US$1,183,777 		19,700 -23.0% 60.09 US$1,183,777
2019-09-20 2019-09-19 PlS Planned sale
Lee June

EVP, Chief Development Officer
5,435 -54.3%
57.08
US$310,254 		5,435 -54.3% 57.08 US$310,254
2019-09-12 2019-09-11 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.0%
55.00
US$55,000 		1,000 -1.0% 55.00 US$55,000
2019-09-05 2019-09-03 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,100 -1.1%
54.09
US$59,500 		1,100 -1.1% 54.09 US$59,500
2019-09-05 2019-09-03 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.0%
52.75
US$52,750 		1,000 -1.0% 52.75 US$52,750
2019-09-05 2019-09-03 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,900 -1.8%
50.70
US$96,335 		1,900 -1.8% 50.70 US$96,335
2019-08-12 2019-08-09 PlS Planned sale Lee June

EVP, Chief Development Officer

Officer
4,565 -49.9%
57.00
US$260,219 		4,565 -49.9% 57.00 US$260,219
2019-08-09 2019-08-08 PlS Planned sale GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -0.9%
55.09
US$55,090 		1,000 -0.9% 55.09 US$55,090
2019-08-05 2019-08-02 PlS Planned sale GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
200 -0.2%
53.82
US$10,764 		200 -0.2% 53.82 US$10,764
2019-08-05 2019-08-02 PlS Planned sale GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
3,800 -3.4%
53.20
US$202,171 		3,800 -3.4% 53.20 US$202,171
2019-07-23 2019-07-22 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -0.9%
55.00
US$55,000 		1,000 -0.9% 55.00 US$55,000
2019-07-08 2019-07-05 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,450 -2.1%
50.10
US$122,752 		2,450 -2.1% 50.10 US$122,752
2019-07-08 2019-07-05 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,550 -1.3%
49.13
US$76,151 		1,550 -1.3% 49.13 US$76,151
2019-04-09 2019-04-05 S Sale
0.5
Harris Taylor C.

Chief Financial Officer
1,324 -35.3%
53.30
US$70,569 		1,324 -35.3% 53.30 US$70,569
2019-02-15 2019-02-13 S Sale
2.4
Sanofi
Large shareholder
4,168,899 -100.0%
37.66
US$157,000,736 		4,168,899 -100.0% 37.66 US$157,000,736
2019-01-11 2019-01-07 S Sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,770 -3.5%
44.11
US$122,197 		2,770 -3.5% 44.11 US$122,197
2019-01-08 2019-01-04 B Purchase
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,600 +1.8%
39.87
US$63,796 		1,600 +1.8% 39.87 US$63,796
Explore more

More insider trading research around MyoKardia Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America